These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1513 related items for PubMed ID: 9546347
1. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, Trojanowski JQ, Iwatsubo T. Am J Pathol; 1998 Apr; 152(4):879-84. PubMed ID: 9546347 [Abstract] [Full Text] [Related]
2. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein]. Iwatsubo T. Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099 [Abstract] [Full Text] [Related]
3. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease. Iwatsubo T. J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119 [Abstract] [Full Text] [Related]
4. [The mechanism of Lewy body formation in Parkinson's disease]. Wakabayashi K, Takahashi H. Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441 [Abstract] [Full Text] [Related]
5. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study. Jellinger KA. Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452 [Abstract] [Full Text] [Related]
6. Synphilin-1 is present in Lewy bodies in Parkinson's disease. Wakabayashi K, Engelender S, Yoshimoto M, Tsuji S, Ross CA, Takahashi H. Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166 [Abstract] [Full Text] [Related]
7. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies. Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M. Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110 [Abstract] [Full Text] [Related]
8. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS, Shen J, Takio K, Iwatsubo T. Nat Cell Biol; 2002 Feb 02; 4(2):160-4. PubMed ID: 11813001 [Abstract] [Full Text] [Related]
9. Alteration in alpha-synuclein mRNA expression in Parkinson's disease. Kingsbury AE, Daniel SE, Sangha H, Eisen S, Lees AJ, Foster OJ. Mov Disord; 2004 Feb 02; 19(2):162-70. PubMed ID: 14978671 [Abstract] [Full Text] [Related]
10. Lewy bodies in Betz cells of the motor cortex in a patient with Parkinson's disease. Wakabayashi K, Mori F, Oyama Y, Kurihara A, Kamada M, Yoshimoto M, Takahashi H. Acta Neuropathol; 2003 Feb 02; 105(2):189-92. PubMed ID: 12536231 [Abstract] [Full Text] [Related]
11. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies. Sasaki K, Doh-ura K, Wakisaka Y, Iwaki T. Acta Neuropathol; 2002 Sep 02; 104(3):225-30. PubMed ID: 12172907 [Abstract] [Full Text] [Related]
12. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders. Wakabayashi K, Engelender S, Tanaka Y, Yoshimoto M, Mori F, Tsuji S, Ross CA, Takahashi H. Acta Neuropathol; 2002 Mar 02; 103(3):209-14. PubMed ID: 11907799 [Abstract] [Full Text] [Related]
13. Fatal attractions: abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia. Trojanowski JQ, Goedert M, Iwatsubo T, Lee VM. Cell Death Differ; 1998 Oct 02; 5(10):832-7. PubMed ID: 10203692 [Abstract] [Full Text] [Related]
14. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions. Tsuchiya K, Tajima H, Kuwae T, Takeshima T, Nakano T, Tanaka M, Sunaga K, Fukuhara Y, Nakashima K, Ohama E, Mochizuki H, Mizuno Y, Katsube N, Ishitani R. Eur J Neurosci; 2005 Jan 02; 21(2):317-26. PubMed ID: 15673432 [Abstract] [Full Text] [Related]
15. Lewy bodies in progressive supranuclear palsy. Mori H, Oda M, Komori T, Arai N, Takanashi M, Mizutani T, Hirai S, Mizuno Y. Acta Neuropathol; 2002 Sep 02; 104(3):273-8. PubMed ID: 12172913 [Abstract] [Full Text] [Related]
16. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT. J Neuropathol Exp Neurol; 1998 Apr 02; 57(4):334-7. PubMed ID: 9600226 [Abstract] [Full Text] [Related]
17. Controversy: is Parkinson's disease a single disease entity? Yes. Takahashi H, Wakabayashi K. Parkinsonism Relat Disord; 2005 Jun 02; 11 Suppl 1():S31-7. PubMed ID: 15885626 [Abstract] [Full Text] [Related]
18. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gómez C, Ambrosio S. J Neural Transm (Vienna); 2001 Jun 02; 108(12):1383-96. PubMed ID: 11810403 [Abstract] [Full Text] [Related]
19. Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies. Campbell BC, Li QX, Culvenor JG, Jäkälä P, Cappai R, Beyreuther K, Masters CL, McLean CA. Neurobiol Dis; 2000 Jun 02; 7(3):192-200. PubMed ID: 10860784 [Abstract] [Full Text] [Related]
20. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions. Popescu A, Lippa CF, Lee VM, Trojanowski JQ. Arch Neurol; 2004 Dec 02; 61(12):1915-9. PubMed ID: 15596612 [Abstract] [Full Text] [Related] Page: [Next] [New Search]